|
Volumn 11, Issue 7, 2004, Pages 24-
|
Add-on sibutramine for olanzapine-induced weight gain
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
CLOZAPINE;
DOPAMINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
METFORMIN;
NEUROLEPTIC AGENT;
NIZATIDINE;
NORADRENALIN;
OLANZAPINE;
ORAL ANTIDIABETIC AGENT;
PSYCHOTROPIC AGENT;
SEROTONIN;
SIBUTRAMINE;
TOPIRAMATE;
ADD ON THERAPY;
ADULT;
ANOREXIA;
ANTICHOLINERGIC EFFECT;
BODY MASS;
BODY WEIGHT DISORDER;
CARDIOVASCULAR RISK;
CATECHOLAMINE RELEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMOGRAPHY;
DEPRESSION;
DIABETES MELLITUS;
DOUBLE BLIND PROCEDURE;
DRUG DEPENDENCE;
DRUG MECHANISM;
HEADACHE;
HUMAN;
HYPERTENSION;
HYPERTRIGLYCERIDEMIA;
HYPOMANIA;
INSOMNIA;
OBESITY;
PANIC;
PSYCHOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SCHIZOAFFECTIVE PSYCHOSIS;
SCHIZOPHRENIA;
SIDE EFFECT;
STATISTICAL SIGNIFICANCE;
TACHYCARDIA;
WEIGHT GAIN;
XEROSTOMIA;
|
EID: 3442876113
PISSN: 10826319
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (5)
|
References (9)
|